Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Total Non-Current Liabilities (2010 - 2025)

Siga Technologies' (SIGA) quarterly Total Non-Current Liabilities came in at $18.0 million in Q4 2025, down 28.97% on a YoY basis from $25.3 million in Q4 2024, and down 27.57% quarter-over-quarter from $24.8 million in Q3 2025.

Analysis

Siga Technologies (SIGA) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Total Non-Current Liabilities for 16 consecutive years, with $18.0 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 28.97% year-over-year to $18.0 million; the trailing twelve-month figure through Dec 2025 stood at $18.0 million (down 28.97% YoY), and the FY2025 full-year result was $18.0 million, down 28.97% from the prior year.
  • Total Non-Current Liabilities eased to $18.0 million in Q4 2025 per SIGA's latest filing, from $24.8 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $74.8 million in Q1 2024 and bottomed at $10.4 million in Q1 2021.
  • Historically, Total Non-Current Liabilities has averaged $25.7 million across 5 years, with a median of $22.5 million in 2021.
  • The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities jumped 304.9% in 2024, then slumped 62.84% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $33.9 million in 2021, then tumbled by 36.51% to $21.5 million in 2022, then jumped by 151.5% to $54.1 million in 2023, then plunged by 53.19% to $25.3 million in 2024, then fell by 28.97% to $18.0 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $18.0 million, $24.8 million, and $22.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 105.99 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 106.45 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 16.16 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 48.34 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 100.86 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 32.04 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 1.53 Bn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 1.40 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 607.80 Mn
10 Siga Technologies 220.19 Mn 65.22 Mn - 17.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 17.99 Mn
Sep 30, 2025 24.84 Mn
Jun 30, 2025 22.72 Mn
Mar 31, 2025 27.80 Mn
Dec 31, 2024 25.33 Mn
Sep 30, 2024 22.30 Mn
Jun 30, 2024 21.38 Mn
Mar 31, 2024 74.81 Mn
Dec 31, 2023 54.12 Mn
Sep 30, 2023 30.74 Mn
Jun 30, 2023 18.99 Mn
Mar 31, 2023 18.48 Mn
Dec 31, 2022 21.52 Mn
Sep 30, 2022 27.46 Mn
Jun 30, 2022 16.69 Mn
Mar 31, 2022 10.64 Mn
Dec 31, 2021 33.89 Mn
Sep 30, 2021 22.66 Mn
Jun 30, 2021 11.67 Mn
Mar 31, 2021 10.36 Mn